Copy Link Print Information

Bafisontamab

(Synonyms: EMB-01)
Revisión del cliente

Based on 1 Customer Validation

Bafisontamab (EMB-01) is a bispecific antibody targeting EGFR and cMET with antitumor activity.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.9%
  • No. CAS: 2437210-79-0
  • Peso molecular:237.63 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Bafisontamab
  • Experimental Validation Results for Bafisontamab
  • Experimental Validation Results for Bafisontamab
  • Experimental Validation Results for Bafisontamab
  • Experimental Validation Results for Bafisontamab
  • Bafisontamab Chemical Structure
    Bafisontamab Chemical Structure
No. CAS: 2437210-79-0
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Bafisontamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Ver todos los productos específicos de isoformas EGFR

More

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    [(G1 VK-CK-VH-CH1-h-CH2-CH3_L-kappa)_VH-CH1]-dimer

  • 1/16

    Immobilized Bafisontamab can bind Human EGFR Protein (ECD, His Tag). The EC50for this effect is 3.76 ng/mL.

  • 1/16

    Immobilized Bafisontamab can bind Human c-MET/HGFR Protein (ECD, His Tag). The EC50 for this effect is 3.28 ng/mL.

  • 1/16

    Flow Cytometry analysis of Hela cells labelling EGFR (red) with Bafisontamab (HY-P99455). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Flow cytometric analysis of 1X106 HT-29 cells labeling MET with Bafisontamab (HY-P99455, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 for an hour at 4℃. AF488-conjugated Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Bafisontamab Chemical Structure
    1/16
  • Bafisontamab
  • Immobilized Bafisontamab can bind Human EGFR Protein (ECD, His Tag). The EC50for this effect is 3.76 ng/mL.
  • Immobilized Bafisontamab can bind Human c-MET/HGFR Protein (ECD, His Tag). The EC50 for this effect is 3.28 ng/mL.
  • Flow Cytometry analysis of Hela cells labelling EGFR (red) with Bafisontamab (HY-P99455). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Flow cytometric analysis of 1X106 HT-29 cells labeling MET with Bafisontamab (HY-P99455, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 for an hour at 4℃. AF488-conjugated Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • [(G1 VK-CK-VH-CH1-h-CH2-CH3_L-kappa)_VH-CH1]-dimer